Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 17, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences
Wednesday, October 09, 2013
The model of infection used to test and benchmark antimicrobial drugs.

Hepregen Launches First Dual-Species HepatoPac™ DMPK Assay Kits
Wednesday, September 25, 2013
Rat and human liver cells on a single tissue culture plate designed for high efficiency data collection.

Molecular Devices Introduces EarlyTox Cardiotoxicity Kit
Wednesday, September 18, 2013
The EarlyTox™ Cardiotoxicity Kit is a fast, simple and reliable fluorescence-based kit for identifying cardiotoxicity of drug candidates early in the discovery process.

Agilent to Demonstrate Mobile Forensics Laboratory at Criminalistica 2013
Monday, September 09, 2013
Criminalistics conference in Brazil will take place on 14-19 September.

Food Safety Testing, Environmental Analysis and Forensic Toxicology Made Simple with New AB SCIEX Software
Tuesday, September 03, 2013
MasterView™ Software improves ability to identify known and unknown compounds in automated process.

Gentronix Extends Toxicology Screening Services to Apoptosis
Tuesday, August 13, 2013
Company adds apoptosis testing to provide follow-up for micronucleus positive results.

Pace of Designer Drugs Increases Year on Year
Monday, August 12, 2013
Science needs to work hard to keep pace with clandestine designer drugs labs – that was the hard-hitting message delivered to delegates at AACC Clinical Lab Expo.

Agilent Enhances Dissolution Workstation Software
Friday, August 02, 2013
Greater instrument control and improved monitoring of pharmaceutical ingredients.

Hurel Corporation Launches Cell-Based In Vitro Testing Product Suite
Wednesday, July 17, 2013
Suite is milestone in movement away from use of live animals in drug and toxicity testing.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 647
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv